731 studies found for:
"Hepatitis B"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 |
Completed
Has Results |
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
|
||||
| 2 |
Completed
Has Results |
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
|
||||
| 3 | Completed |
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
|
||||
| 4 |
Active, not recruiting
Has Results |
Lamivudine and Adefovir to Treat Chronic Hepatitis B
|
||||
| 5 | Recruiting |
Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
|
||||
| 6 | Recruiting |
Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
|
||||
| 7 |
Completed
Has Results |
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
|
||||
| 8 |
Completed
Has Results |
Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
|
||||
| 9 | Recruiting |
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
|
||||
| 10 |
Completed
Has Results |
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
|
||||
| 11 | Recruiting |
Observational Study of Persons With Hepatitis B Virus Infection in North America
|
||||
| 12 | Terminated |
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
|
||||
| 13 | Completed |
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
|
||||
| 14 | Completed |
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
|
||||
| 15 | Completed |
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
|
||||
| 16 | Completed |
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients
|
||||
| 17 | Active, not recruiting |
Therapeutic Hepatitis B Vaccine (Synthesized Peptide) in Treating Chronic Hepatitis B Patients
|
||||
| 18 | Active, not recruiting |
Therapeutic Hepatitis B Vaccine (Synthesized Peptide εPA-44) Joint Entecavir in Treating Chronic Hepatitis B Patients
|
||||
| 19 | Active, not recruiting |
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
|
||||
| 20 | Unknown † |
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B
|
† Indicates status has not been verified in more than two years
